Document Detail


Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes.
MedLine Citation:
PMID:  21975761     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Maternal nutrition during pregnancy is known to have an effect on fetal growth and development. It is recommended that women increase their calcium intake during pregnancy and lactation, although the recommended dosage varies among professionals. Currently, there is no consensus on the role of routine calcium supplementation for pregnant women other than for preventing or treating hypertension.
OBJECTIVES: To determine the effect of calcium supplementation on maternal, fetal and neonatal outcomes (other than for preventing or treating hypertension) as well as any possible side effects.
SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (17 March 2011).
SELECTION CRITERIA: We considered all published, unpublished and ongoing randomised controlled trials (RCTs) comparing maternal, fetal and neonatal outcomes in pregnant women who received calcium supplementation versus placebo or no treatment. We excluded quasi- and pseudo-RCTs.
DATA COLLECTION AND ANALYSIS: Two review authors identified studies for inclusion and extracted the data. Two review authors performed data analysis.
MAIN RESULTS: This review includes data from 21 studies (involving 16,602 women). There were no statistically significant differences between women who received calcium supplementation and those who did not in terms of reducing preterm births (less than 37 weeks' gestation) (risk ratio (RR) 0.90; 95% confidence interval (CI) 0.73 to 1.11; 12 studies, 15615 women; random-effects model) and also in less than 34 weeks' gestation (RR 1.11; 95% CI 0.84 to 1.46; three trials, 5145 women). There was no significant difference in infant low birth weight between the two groups (RR 0.91; 95% CI 0.72 to 1.16; four trials, 13449 infants; random-effects). However, compared to the control group, women in the calcium supplementation group gave birth to slightly heavier birth weight infants (mean difference (MD) 64.66 g; 95% CI 15.75 to 113.58; 19 trials, 8287 women; random-effects).
AUTHORS' CONCLUSIONS: Calcium supplementation is associated with a significant protective benefit in the prevention of pre-eclampsia, and should be used for this indication according to a previous review. This review indicates that there are no additional benefits for calcium supplementation in prevention of preterm birth or low infant birth weight. While there was a statistically significant difference of 80 g identified in mean infant birth weight, there was significant heterogeneity identified, and the clinical significance of this difference is uncertain.
Authors:
Pranom Buppasiri; Pisake Lumbiganon; Jadsada Thinkhamrop; Chetta Ngamjarus; Malinee Laopaiboon
Publication Detail:
Type:  Journal Article; Meta-Analysis; Review     Date:  2011-10-05
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  -     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2011  
Date Detail:
Created Date:  2011-10-06     Completed Date:  2011-11-02     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD007079     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, Faculty of Medicine, Khon Kaen University, Faculty of Medicine, Khon Kaen, Khon Kaen, Thailand, 40002.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Birth Weight
Calcium, Dietary / administration & dosage*,  adverse effects
Dietary Supplements* / adverse effects
Female
Humans
Infant, Low Birth Weight*
Infant, Newborn
Pre-Eclampsia / prevention & control
Pregnancy
Pregnancy Outcome*
Premature Birth / prevention & control*
Prenatal Nutritional Physiological Phenomena*
Randomized Controlled Trials as Topic
Chemical
Reg. No./Substance:
0/Calcium, Dietary
Comments/Corrections
Comment In:
Evid Based Med. 2012 Dec;17(6):186-7   [PMID:  22736659 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tocolytics for preterm premature rupture of membranes.
Next Document:  Dance/movement therapy for improving psychological and physical outcomes in cancer patients.